Mark Pruzanski
2015
In 2015, Mark Pruzanski earned a total compensation of $6.2M as Chief Executive Officer and President at Intercept Pharmaceuticals, a 92% increase compared to previous year.
Compensation breakdown
| Bonus | $420,000 |
|---|---|
| Option Awards | $2,867,210 |
| Salary | $600,000 |
| Stock Awards | $2,308,606 |
| Other | $4,627 |
| Total | $6,200,443 |
Pruzanski received $2.9M in option awards, accounting for 46% of the total pay in 2015.
Pruzanski also received $420K in bonus, $600K in salary, $2.3M in stock awards and $4.6K in other compensation.
Rankings
In 2015, Mark Pruzanski's compensation ranked 1,178th out of 13,638 executives tracked by ExecPay. In other words, Pruzanski earned more than 91.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,178 out of 13,638 | 91st |
Division Manufacturing | 415 out of 5,187 | 92nd |
Major group Chemicals And Allied Products | 151 out of 1,857 | 92nd |
Industry group Drugs | 115 out of 1,531 | 93rd |
Industry Pharmaceutical Preparations | 94 out of 1,179 | 92nd |
Source: SEC filing on June 20, 2016.
Pruzanski's colleagues
We found five more compensation records of executives who worked with Mark Pruzanski at Intercept Pharmaceuticals in 2015.
2015
Lisa Bright
Intercept Pharmaceuticals
Chief Commercial and Corporate Affairs Officer
2015
David Shapiro
Intercept Pharmaceuticals
Chief Medical Officer
2015
Barbara Duncan
Intercept Pharmaceuticals
Chief Financial Officer
2015
Rachel McMinn
Intercept Pharmaceuticals
Chief Strategy and Business Officer
2015
Daniel Regan
Intercept Pharmaceuticals